Alex Carchidi
TMFacarchidi
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.
Recent Articles by Alex Carchidi

Mar 31, 2025
by Alex Carchidi
Better Buy Right Now With $2,000: Bitcoin or Solana?

Apr 1, 2025
by Alex Carchidi
Is Cardano Still a Smart Long-Term Hold?

Mar 31, 2025
by Alex Carchidi
Better Buy With $5,000 Right Now: Ethereum or XRP?

Mar 26, 2025
by Alex Carchidi
Is This 1 Sign a Problem for XRP?

Mar 26, 2025
by Alex Carchidi
This 1 Overlooked Metric Could Send Solana to $500
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.